Yan Fei, Li Jiamin, Zhu Murong, Zhao Ke, Han Jiasheng, Wang Yan, Fang Lei, Xue Peng
Department of Pediatrics, Affiliated Hospital of Shandong Second Medical University, Weifang, 261200, China.
School of Public Health, Shandong Second Medical University, Weifang, 261053, China.
J Ethnopharmacol. 2025 Sep 25;353(Pt A):120378. doi: 10.1016/j.jep.2025.120378. Epub 2025 Aug 5.
Oligoasthenozoospermia (OA) is the main factor leading to male infertility. According to traditional Chinese medicine, ginseng and its derivatives can improve male sperm quality by nourishing the kidneys and replenishing qi. Ginsenosides have been recognized as the principal pharmacologically active constituents of Panax ginseng, and are generally categorized into highly polar and rare ginsenosides. Rare ginsenosides can be generated through thermal transformation of the highly polar forms, yielding structurally related compounds collectively referred to as heat-transformed saponins (HTS). HTS comprising Rg6, F4, Rg3, Rk1, and Rg5-demonstrate substantial bioactivity at a dose of 50 mg/kg without observable toxicity. However, their effects on oligoasthenospermia (OA) and the associated molecular mechanisms remain poorly defined.
To determine whether HTS can mitigate sperm damage caused by cyclophosphamide (CP) and elucidate their potential mechanism of action.
Rare ginsenosides (HTS) were prepared in our laboratory. CP was used to construct an OA model. HTS were either administered prior to CP modelling to create a prevention group (HTS-CP) or after CP modelling to create a treatment group (CP-HTS). The intervention effect of HTS was evaluated using indicators such as sperm quality, hormone levels, and the degree of inflammation.
In this study, HTS significantly increased the sperm count, improved sperm motility, and ameliorated testicular tissue damage. HTS decreased the elevation in follicle-stimulating hormone (FSH), lactate dehydrogenase (LDH), malondialdehyde (MDA), and inflammatory factor levels caused by CP and increased the levels of testosterone (T), luteinizing hormone (LH), acid phosphatase (ACP), alkaline phosphatase (AKP), superoxide dismutase (SOD), and glutathione peroxidase (GSH) in the model group. HTS significantly increased the gene and protein expression levels of PUMA and Bcl-2 in testicular tissue and significantly decreased the gene and protein expression levels of Bax and caspase-3.
This study revealed that HTS can effectively ameliorate CP-induced damage to male sperm by inhibiting apoptosis via the Bcl-2/Bax/cleaved caspase-3 pathway.
少弱精子症(OA)是导致男性不育的主要因素。根据传统中医理论,人参及其衍生物可通过补肾益气来提高男性精子质量。人参皂苷已被公认为人参的主要药理活性成分,一般分为高极性人参皂苷和稀有人参皂苷。稀有人参皂苷可通过高极性人参皂苷的热转化生成,产生结构相关的化合物,统称为热转化皂苷(HTS)。包含Rg6、F4、Rg3、Rk1和Rg5的HTS在剂量为50mg/kg时显示出显著的生物活性且无明显毒性。然而,它们对少弱精子症(OA)的影响及其相关分子机制仍不清楚。
确定HTS是否能减轻环磷酰胺(CP)引起的精子损伤并阐明其潜在作用机制。
在我们实验室制备了稀有人参皂苷(HTS)。使用CP构建OA模型。HTS在CP建模前给药以创建预防组(HTS-CP),或在CP建模后给药以创建治疗组(CP-HTS)。使用精子质量、激素水平和炎症程度等指标评估HTS的干预效果。
在本研究中,HTS显著增加精子数量,提高精子活力,并改善睾丸组织损伤。HTS降低了CP引起的促卵泡激素(FSH)、乳酸脱氢酶(LDH)、丙二醛(MDA)和炎症因子水平的升高,并提高了模型组中睾酮(T)、黄体生成素(LH)、酸性磷酸酶(ACP)、碱性磷酸酶(AKP)、超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH)的水平。HTS显著提高睾丸组织中PUMA和Bcl-2的基因和蛋白表达水平,并显著降低Bax和caspase-3的基因和蛋白表达水平。
本研究表明,HTS可通过Bcl-2/Bax/cleaved caspase-3途径抑制细胞凋亡,有效减轻CP诱导的男性精子损伤。